The impact of initiating rivaroxaban versus low-molecular weight heparin plus warfarin in patients admitted to the hospital for venous thromboembolism

被引：2
|
作者：
Hom, Lindsay [1 ]
Sobieraj, Diana M. [2 ]
机构：
[1] Hartford Hosp, Serv Pharm, Hartford, CT 06102 USA
[2] Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT 06269 USA
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 198卷
关键词：
Venous thromboembolism; Anticoagulant; Rivaroxaban; DEEP-VEIN THROMBOSIS; LENGTH-OF-STAY;
D O I：
10.1016/j.ijcard.2015.06.060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [1] Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies
    Choe, Hannah K.
    De Sancho, Maria T.
    Kim, Sunnie S.
    Dai, Tong
    Shah, Manish A.
    BLOOD COAGULATION & FIBRINOLYSIS, 2018, 29 (02) : 227 - 230
  • [2] Low-molecular heparin in venous thromboembolism
    Stammler, F
    Diehm, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 123 (19) : 604 - 611
  • [3] Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism in gastrointestinal and pancreatobiliary cancer
    Lee, Jang Ho
    Lee, Jae Seung
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
    Lee, Jang Ho
    Oh, Yeon-Mok
    Lee, Sang-Do
    Lee, Jae Seung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (21)
  • [5] Cost-Effectiveness Analysis of Warfarin Versus Low-Molecular Weight Heparin for the Treatment of Malignancy-Associated Venous Thromboembolism
    Connell, Nathan T.
    Abel, Gregory A.
    Connors, Jean M.
    BLOOD, 2015, 126 (23)
  • [6] PREVENTION OF POSTOPERATIVE VENOUS THROMBOEMBOLISM BY A LOW-MOLECULAR WEIGHT HEPARIN FRACTION
    KAKKAR, VV
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 91 - 91
  • [7] Initiation of rivaroxaban following low molecular weight heparin for venous thromboembolism prophylaxis
    Mills, R. M.
    Damaraju, C. R., V
    Jennings, L. K.
    Wildgoose, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 860 - 860
  • [8] Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: A randomized trial
    Das, SK
    Cohen, AT
    Edmondson, RA
    Melissari, E
    Kakkar, VV
    WORLD JOURNAL OF SURGERY, 1996, 20 (05) : 521 - 527
  • [9] Cost of Treating Venous Thromboembolism With Heparin and Warfarin Versus Home Treatment With Rivaroxaban
    Kahler, Zachary P.
    Beam, Daren M.
    Kline, Jeffrey A.
    ACADEMIC EMERGENCY MEDICINE, 2015, 22 (07) : 796 - 802
  • [10] PREVENTION OF POSTOPERATIVE VENOUS THROMBOEMBOLISM BY A NEW LOW-MOLECULAR WEIGHT HEPARIN FRACTION
    KAKKAR, VV
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1984, 26 (04): : 277 - 282
12345